T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Immunology today (Amsterdam. Regular ed.)

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0167-5699(94)90005-1PMID 7915115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS.

  2009cited by this paper
• Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.

  1993cited by this paper
• Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease

  1993cited by this paper
• Survival experience of 789 children with the acquired immunodeficiency syndrome.

  1993cited by this paper
• Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells

  1993cited by this paper
• Apoptosis in AIDS.

  1993cited by this paper
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

  1993cited by this paper
• Virulent HIV strains?

  1993cited by this paper
• Antigen presentation, loss of immunological memory and AIDS.

  1993cited by this paper
• T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

  1993cited by this paper
• Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

  1993cited by this paper
• A case for cytokines as effector molecules in the resolution of virus infection.

  1993cited by this paper
• HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

  1993cited by this paper
• THE EFFECT OF CYCLOSPORINE ON THE PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION TRANSMITTED BY TRANSPLANTATION–DATA ON FOUR CASES AND REVIEW OF THE LITERATURE

  1993cited by this paper
• Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy.

  1992cited by this paper
• Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

  1992cited by this paper
• Induction of antigen‐specific tolerance by cyclosporin A

  1992cited by this paper
• Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

  1992cited by this paper
• Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry.

  1992cited by this paper
• Hepatitis B virus and hepatocellular carcinoma.

  1992cited by this paper
• The pathobiology of HIV infection.

  1992cited by this paper
• Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection

  1991cited by this paper
• Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

  1991cited by this paper
• Games that viruses play

  1991cited by this paper
• Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication

  1991cited by this paper
• Vaccination for disease.

  1991cited by this paper
• An idiotypic network model of AIDS immunopathogenesis.

  1991cited by this paper
• A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.

  1991cited by this paper
• HIV. Games that viruses play.

  1991cited by this paper
• Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.

  1991cited by this paper
• Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

  1991cited by this paper
• Early T-helper cell defects in HIV infection.

  1991cited by this paper
• A central role of perforin in cytolysis?

  1991cited by this paper
• Immunology and the liver

  1991cited by this paper
• Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells.

  1990cited by this paper
• Why the long latent period?

  1990cited by this paper
• A cell culture model for T lymphocyte clonal anergy.

  1990cited by this paper
• Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.

  1990cited by this paper
• HIV infection. Why the long latent period?

  1990cited by this paper
• Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.

  1989cited by this paper
• Cyclosporine-induced deterioration in patients with AIDS.

  1989cited by this paper
• The immunopathogenesis of HIV infection.

  1989cited by this paper
• Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.

  1989cited by this paper
• Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

  1989cited by this paper
• Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.

  1989cited by this paper
• Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells

  1988cited by this paper
• Biologically diverse molecular variants within a single HIV-1 isolate

  1988cited by this paper
• Mysteries of HIV: challenges for therapy and prevention

  1988cited by this paper
• Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease.

  1988cited by this paper
• Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV).

  1987cited by this paper
• AIDS virus-specific cytotoxic T lymphocytes in lung disorders

  1987cited by this paper
• An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells

  1987cited by this paper
• Prospects for the control of AIDS by immunizing seropositive individuals

  1987cited by this paper
• Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes.

  1986cited by this paper
• Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein

  1986cited by this paper
• Distortion of cell functions by noncytotoxic viruses.

  1986cited by this paper
• CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

  1986cited by this paper
• Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

  1986cited by this paper
• Mechanisms of Liver Cell Injury in Acute and Chronic Hepatitis B

  1984cited by this paper
• The virology and immunobiology of lymphocytic choriomeningitis virus infection.

  1980cited by this paper
• A new analysis of allogeneic interactions.

  1975cited by this paper
• Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B

  1974cited by this paper
• Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice.

  1973cited by this paper
• Pathogenesis of lesions in lymphoid tissue of mice infected with lymphocytic choriomeningitis (LCM) virus.

  1969cited by this paper

• Phytochemicals and HIV Suppression: A Systematic Review

  2023cites this paper
• Anatomical and physiological aspects of the HIV infection pathogenesis in animal models

  2022cites this paper
• The CD8+ T Cell Noncytotoxic Antiviral Responses

  2021cites this paper
• Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19

  2021cites this paper
• What if protective immunity is antigen—driven and not due to so‐called “memory” B and T cells?

  2018cites this paper
• Viral‐specific T‐cell response in hemorrhagic cystitis after haploidentical donor stem cell transplantation

  2017cites this paper
• Title : Timing of CD 8 T cell effector responses in viral infections

  2016cites this paper
• Timing of CD8 T cell effector responses in viral infections

  2016cites this paper
• System Biology Models and Conceptualizations Applied to Eco-Immunology

  2014cites this paper
• Proviral load and expression of avian leukosis viruses of subgroup C in long-term persistently infected heterologous hosts (ducks)

  2014influential citation
• Intersection of population variation and autoimmunity genetics in human T cell activation

  2014cites this paper
• Modeling T cell responses to antigenic challenge

  2014cites this paper
• Cell Activation and Apoptosis in HIV Infection

  2012cites this paper
• indivíduos infectados pelo HTLV-1 com paraparesia espástica tropical (HAM/TSP)

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Tangible effects of antiretroviral therapy in HIV-1 infected patients

  2012cites this paper
• The Immune Response to Acute HIV-1 Infection and the Effect of HAART and HLA Alleles on the Control of Viral Replication

  2012cites this paper
• Regulation and role of IL-7 production in HIV-1 infection

  2011cites this paper
• Virus-Host Interactions in HIV Pathogenesis: directions for therapy

  2011cites this paper
• Virus-Host Interactions in HIV Pathogenesis

  2011cites this paper
• Similar Impact of CD8+ T Cell Responses on Early Virus Dynamics during SIV Infections of Rhesus Macaques and Sooty Mangabeys

  2010cites this paper
• Limiting the Survival of Dendritic Cells Persistence of Antigen Presentation by Expressed by T Cells Regulates the g IFN-Subash

  2009cites this paper
• IFN-γ Expressed by T Cells Regulates the Persistence of Antigen Presentation by Limiting the Survival of Dendritic Cells1

  2009cites this paper
• HIV pathogenesis: 25 years of progress and persistent challenges

  2009influential citation
• HIV-1 Matrix Protein p17 Prevents Loss of CD28 Expression During IL-2–Induced Maturation of Naïve CD8+ T Cells

  2008cites this paper
• Treating HIV/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivation.

  2008cites this paper
• The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

  2008influential citation
• Increased Loss of CCR5+ CD45RA− CD4+ T Cells in CD8+ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys

  2008cites this paper
• Fas, IL-7, and T cells: live and let die.

  2008cites this paper
• The role of the envelope glycoprotein in the depletion of T helper cells in human immunodeficiency virus infection

  2008cites this paper
• Virus-Induced Immunopathology

  2008cites this paper
• Acutely dysregulated, chronically disabled by the enemy within: T‐cell responses to HIV‐1 infection

  2007cites this paper
• Acquired immunologic tolerance: with particular reference to transplantation

  2007cites this paper
• The biology of dendritic cells and HIV infection

  2007cites this paper
• Immunology and immunity studied with viruses.

  2007cites this paper
• Immunopathogenesis of HIV Infection

  2007cites this paper
• Proliferação celular e citocinas BCG especificos em crianças com AIDS : efeito de suplementos nutricionais

  2007cites this paper
• The unfinished legacy of liver transplantation: Emphasis on immunology

  2006cites this paper
• CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cells.

  2006cites this paper
• HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death

  2006cites this paper
• Immunotherapy of HIV Disease

  2005cites this paper
• Hydroxyurea exerts a cytostatic but not immunosuppressive effect on T lymphocytes

  2005cites this paper
• Immunosuppression for liver transplantation in HCV‐infected patients: Mechanism‐based principles

  2005cites this paper
• Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic (‘virostatic’) mechanisms

  2005cites this paper
• Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency

  2005cites this paper
• Impairment of HIV-Specific Immune Effector Cell Function

  2005cites this paper
• Lentiviral Biology and Cell Death

  2005cites this paper
• Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts

  2005cites this paper
• HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication

  2004cites this paper
• Safety of hydroxyurea in the treatment of HIV infection

  2004cites this paper
• Immune dysregulation and CD4+ T cell loss in HIV-1 infection

  2004cites this paper
• "Virostatics" as a potential new class of HIV drugs.

  2004cites this paper
• Chapter 11 – Immunodeficiency in HIV-1 Infection

  2004cites this paper
• Macrophages exposed to lymphotropic and monocytotropic HIV induce similar CTL responses despite differences in productive infection.

  2004cites this paper
• In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease.

  2004cites this paper
• Strategies to Decrease Viral Load Rebound, and Prevent Loss of Cd4 and Onset of Resistance during Structured Treatment Interruptions

  2004cites this paper
• T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patients.

  2004cites this paper
• Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions

  2003cites this paper
• Hydroxyurea in the Treatment of HIV Infection

  2003cites this paper
• Heterogeneous pathogenicity of retroviruses: lessons from birds, primates, and rodents.

  2003cites this paper
• Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions

  2003cites this paper
• Distinct Cycling CD4+- and CD8+-T-Cell Profiles during the Asymptomatic Phase of Simian Immunodeficiency Virus SIVmac251 Infection in Rhesus Macaques

  2003cites this paper
• [HIV1-associated CD4 T lymphocyte apoptosis].

  2003cites this paper
• Identification of a novel human leucocyte antigen‐A*01‐restricted cytotoxic T‐lymphocyte epitope in the respiratory syncytial virus fusion protein

  2003cites this paper
• Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

  2003cites this paper
• Infection par le VIH1 et apoptose lymphocytaire T CD4

  2003cites this paper
• T cell survival/proliferation reconstitution by trifluoperazine in human immunodeficiency virus-1 infection.

  2003cites this paper
• Balancing effector lymphocyte formation via CD27-CD70 interactions

  2003cites this paper
• Essential Roles for CD8+ T Cells and Gamma Interferon in Protection of Mice against Retrovirus-Induced Immunosuppression

  2002cites this paper
• Contribution of Peaks of Virus Load to Simian Immunodeficiency Virus Pathogenesis

  2002cites this paper
• Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara

  2002cites this paper
• Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.

  2002cites this paper
• Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus.

  2002cites this paper
• Immune Intervention in AIDS

  2002cites this paper
• The Role of Cytotoxic T Lymphocytes in Protection Against HIV Infection and AIDS

  2002cites this paper
• Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus.

  2002cites this paper
• Use of a combination of beta-sitosterol and beta-sitosterol glucoside for the manufactucture of a medicament for treating HIV infection Verwendung einer

  2002cites this paper
• Short-Term Treatment with Novel Ribonucleotide Reductase Inhibitors Trimidox and Didox Reverses Late-Stage Murine Retrovirus-Induced Lymphoproliferative Disease with Less Bone Marrow Toxicity Than Hydroxyurea

  2002cites this paper
• Genetically modified immunocompetent cells in HIV infection

  2001cites this paper
• Factores inmunitarios protectivos del huésped contra la infección por el VIH-1 y la progresión a SIDA: quimiocinas y sus receptores.

  2001cites this paper
• Biochemical mechanisms of HIV induced T cell apoptosis

  2001cites this paper
• MECHANISMS OF HUMAN IMMUNODEFICIENCY VIRUS ( HIV ) ESCAPE FROM THE IMMUNE RESPONSE

  2001cites this paper
• Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.

  2001cites this paper
• The immunology of HIV-infected long-term non-progressors--a current view.

  2001cites this paper
• Neuroendocrine-immune interactions during viral infections.

  2001cites this paper
• Cellular HIV-1 Immune Responses in Natural Infection and After Genetic Immunization

  2001cites this paper
• T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy.

  2001cites this paper
• T-bodies as antiviral agents.

  2001cites this paper
• Cellular HIV-1 immune responses in natural infection and after genetic immunization.

  2001cites this paper
• High Levels of CD8-Positive Lymphocytes Expressing CD45R0, Granzyme B, and Ki-67 in Lymph Nodes of HIV-Infected Individuals Are Not Associated with Increased Mortality

  2001cites this paper
• Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug.

  2000cites this paper
• Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines1

  2000cites this paper
• HIV and the immune system during highly active antiretroviral therapy

  2000cites this paper
• Effects of hydroxyurea on T cell count changes during primary HIV infection.

  2000cites this paper
• On immunological memory.

  2000cites this paper
• Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity

  2000influential citation
• Tumor Necrosis Factor (TNF)-α and TNF Receptors in Viral Pathogenesis (44487)

  2000cites this paper
• The anti‐idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV‐1 infection

  2000cites this paper
• Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120).

  2000cites this paper
• Relationship of Lymphoid Lesions to Disease Course in Mucosal Feline Immunodeficiency Virus Type C Infection

  2000cites this paper
• Interactions Between the Hypothalamic‐Pituitary‐Adrenal Axis and Immune System During Viral Infection: Pathways for Environmental Effects on Disease Expression

  2000cites this paper